(Q74599888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Plasma dexamethasone concentration and cortisol response during manic episodes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

F Cassidy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J C Ritchie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B J Carroll

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

747-754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Plasma dexamethasone and cortisol levels in depressed outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Adverse Effects of Phenobarbital on Corticosteroid Metabolism in Patients with Bronchial Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The effect of serum dexamethasone concentrations in the dexamethasone suppression test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Signs and symptoms of mania in pure and mixed episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

A factor analysis of the signs and symptoms of mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The performance of DSM-III-R major depression criteria in the diagnosis of bipolar mixed states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The dexamethasone suppression test in mixed bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The dexamethasone suppression test in acute mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The dexamethasone suppression test in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Central control of hepatic steroid metabolism and “lactogenic” receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Studies on dexamethasone metabolism in man: effect of diphenylhydantoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Serial dexamethasone suppression test in psychiatric inpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

TRH test and DST in schizoaffective mania, mania, and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The dexamethasone suppression test: importance of dexamethasone concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Dexamethasone kinetics in depressed patients before and after clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Serum dexamethasone concentrations in endogenous depressives before, during, and after treatment: Preliminary observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Plasma dexamethasone concentrations and the dexamethasone suppression test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Hypothalamic-pituitary-adrenocortical function in mixed and pure mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900274-6

10.1016/S0006-3223(97)00274-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606529%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference